SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SRGN ( Seragen, Inc.) -- Ignore unavailable to you. Want to Upgrade?


To: Joe Williamson who wrote (36)5/11/1998 11:52:00 PM
From: Henry Niman  Respond to of 52
 
Info on LGND can be found at Links to Ligand at home.att.net



To: Joe Williamson who wrote (36)5/12/1998 12:49:00 PM
From: PawPr  Read Replies (1) | Respond to of 52
 
It works out to $0.50 if no approval, $0.75 with approval. It takes the risk out of owning the stock, but limits the upside if the drug is approved.